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The concept of office endometrial sam­
pling is not new. Kelly recommended its use in 
1925.' More recently, the procedure has re­
ceived increased attention as physicians and 
the public have sought ways to curb the spiral­
ling cost of medical care. Uterine curettage is 
the operation most commonly performed on 
women throughout the world. As an inpatient 
procedure, it costs $500 to $600. The same 
procedure performed in an outpatient surgical 
center costs $350 to $400. In over 90% of 
cases, an adequate endometrial sample may be 
obtained in the office at a cost of $50 to $60. 
For office endometrial sampling to be accept­
able to the physician, it must be simple to ac­
complish, relatively inexpensive to use, and 
agreeable in terms of patient comfort and mor­
bidity The specimen obtained should be repre­
sentative of the entire endometrium, adequate 
for pathological study, and easily preserved, 
transported, and processed. 
Indications for office endometrial sampling 
are given in the Table. In the adolescent female 
there is rarely an indication for endometrial sam­
pling; however, during the reproductive years 
and thereafter, there are frequent indications for 
sampling. As the endometrium is extremely sen­
sitive to systemic levels of the sex hormones. 
estrogen and progesterone, sampling will help 
determine ovarian function and give indirect evi­
dence of the status of the hypothalamic-pitui­
tary-ovarian axis. Ovulation is usually followed 
by corpus luteum formation. The corpus luteum 
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produces progesterone and causes the endo­
metrium to take on a secretory appearance 
Timed endometrial sampling may be used to 
prove ovulation and evaluate corpus luteum 
function. A delay in the maturation of the endo 
metrium may be taken as evidence of an in­
adequate corpus luteum. Persistence of a pro/ii, 
erative endometrium, without the development 
of a secretory component, is evidence of ano­
vulation. The documentation of anovulation 01 
of inadequate corpus luteum function is impor· 
tant information in an infertility work-up. Chronic 
anovulation with prolonged stimulation of the 
endometrium by unopposed estrogen can lead 
to the development of endometrial hyperplasia 
This is a common cause of abnormal uterine 
bleeding Severe hyperplasia, of the adenoma­
tous or atypical variety, is considered a pre· 
cursor of endometrial carcinoma. Endometnal 
sampling may be used to evaluate the results ol 
hormonal therapy whether it be for the induction 
of ovulation, the eradication of endometrial hy· 
perplasia, or as replacement therapy to control 
the vasomotor symptoms of the menopause. 
The obese. hypertensive, and diabetic patient 
who is considered to be at increased risk for the 
development of endometrial carcinoma. or the 
patient with abnormal endometrial cytology, 
may undergo sampling as a screening proce­
dure in an effort to detect the presence of a pre· 
malignant or malignant condition. 
Absolute contraindications to endometriat 
sampling are acute pelvic infection and preg· 
nancy, if abortion is not desired. Relative con· 
traindications include an inadequate pelvic ex· 
amination, cervical stenosis, marked anterior or 
posterior uterine flexion, and clotting defr· 
ciencies. 
Techniques for sampling the endometrium 
usually produce either a cytologic or a histologic 
preparation. Cytologic preparations, in general, 
are less desirable than histologic preparations 
as they are mme difficult to interpret This is es­
pecially true in lhe detection and grading of 
neoplasms of the endomelrium. Most patholo­
gists are more comfortable u·s.ing histologic 
preparations for the evaluation of endometrial 
disease. 
There are two uterine curetles commonly 
used for office endometrial sampling. The No­
vak curette was developed in 1 91�i, and the 
Vabra Aspirator (Cooper Laboratories, Inc, 
Wayne, New Jersey) in l 96S. Both obtarn histo­
logic specimens. 
The Novak curette has a metal cannula of 
5 mm diameter and a rectangular, serrated' 
opening just proximal to its distal end. A syri.nge 
may be placed on the pro)(iimal er:wl ot the No­
vak curette in order lo apply Sl!!Ction ag.a'msl the 
endometrial lining and improve samphng. The 
Novak curette is especially wen adapted. to ob­
taining endometrial strips f.rom v,arious q1Jad· 
rants of the endometrial cavity for u-se in dating 
the endometrium in order to prove ovulation and 
evaluate corpus luteum function. Kahler, in 
1 969, presented a series of 1 60 patients in 
which he compared biopsies of the endome­
trium taken with the Novak curette with sub­
sequent dilatation and curettage and hysterec­
tomy specimen analysis In his series there was 
a 96% positive correlation between the diagno­
sis obtained using the Novak curette and that 
obtained on subsequent dilatation and curett­
age or hysterectomy. 2 Hofmeister reported on 
over 20,000 biopsies using the Novak curette. 
He sampled all patients over the age of 35 on a 
routine basis and those under the age of 35 
who reported irregular menses. Seventeen per­
cent of these patients who were found to have 
endometrial carcinoma were asymptomatic at 
the time of endometrial sampling. It is on this 
basis that he states that one in five endometrial 
carcinomas are asymptomatic and will not be 
detected without routine endometrial sampling. 
Hofmeister reported an accuracy of 94% using 
the Novak curette.3 
The Vabra Aspirator comes as a dis­
posable unit consisting of a 3 mm metal can­
nula which has a rectangular curette with sharp 
lateral edges located just proximal to its distal 
lip. The metal cannula is attached to a plastic 
TABLE 
Indications for 
Office Endometrial Sampling 
Infertility work-up 
Menstrual disorde,s 
Postmenopausal bleeding 
Hormonal ther-apy 
Scieening for en.dometrial cancer 
Abnormal endometrial cytology 
Follow-up of therapy 
tissue tilter and collection con1ainer. The collec­
li.on ool'ltainer must be attache.d to a vacuum 
source supplyirig a negative pressure of approx­
imately 1. 6.0 mm Hg. With suction applied by 
the o©ClusiCi>n of holes in the proximal end of the 
cannula, the curette shoYld be swept in a rotary 
taslrli.on about the,eAtire endometrial cavity. The 
S@eci.meµ will be tr-apped in the plastic filter. 
When the procedure is completed, suction is 
dis�onneated. The cmelle is r,emoved from the 
pla&t,ic GGnt:ainer. fi�ative i.s ad.ded to the speci­
men. and ,the plastic container is capped. The 
Vat,ra Aspliator costs approximately $1 2 and is 
disposable. Discomfort caused by Vabra curett­
age has been equa1ed to that of an intrauterine 
contraception dev,ice insertion. The procedure 
has me1 with. a high degree of physician and pa­
tient acceptance. The Walter Reed Army Hospi­
tal has reported 95% accuracy in 300 cases of 
Vabra wreltage foll.owe.a by a subsequent gy­
necologic dilatation and curettage performed in 
order to compare pathologic diagnoses. In that 
series. one third of the patients were sampled 
without anesthesia and two thirds with para­
cetvical block anesthesia. The paracervical 
block anesthesia did not significantly increase 
the acceptance of the procedure, although it re­
duced the percentage of patients who reported 
that they experienced "severe" pain. Ninety­
four percent of the patients who have had both 
the Vabra curettage and subsequent gyneco­
logic dilatation and curettage stated that they 
would prefer to have the Vabra curettage rather 
than an inpatient dilatation and curettage if this 
were indicated at a future date.• 
If office endometrial sampling is to be per­
formed, the patient should be put at ease with 
an explanation of why the procedure is being 
done, how it is going to be performed, and what 
she should expect in the way of discomfort and 
bleeding. An adequate pelvic examination must 
be performed in order to determine uterine size 
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and position. A uterus which is over 8 to 1 0 
weeks gestational size is not ideal for office en­
dometrial sampling. If it is decided to proceed 
with sampling, the cervix should be cleansed 
with an antiseptic solution and a tenaculum 
placed on the anterior lip of the cervix so that 
traction will straighten the uterine canal. The 
uterus should be sounded in order to determine 
the direction and depth of the uterine canal. The 
sampling device may then be inserted and the 
specimen collected. The specimen may be pre­
served in formaldehyde solution. 
Complications associated with endome­
trial sampling are similar to those of dilatation 
and curettage but rarely require surgical man­
agement. The most frequent complications are 
uterine perforation, hemorrhage, infection, syn­
cope and pain. Drug sensitivity, if it occurs, is 
related to the use of systemic analgesia and 
paracervical block anesthesia. 
It must be emphasized that if the physi­
cian is unable to obtain an adequate tissue 
specimen or the pathologist is unable to render 
an absolute diagnosis on the tissue specimen, 
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office endometrial sampling must then be foll: 
lowed by a more thorough inpatient uterine dilai 
talion and curettage performed under anesl· 
thesia. This is to stress the fact that althoug� 
over 90% of all cases in which endometrial1 ' 
sampling is indicated can be handled as an o\ 
lice procedure, at least 1 0% of all cases need" 
ing sampling must have it performed on an in-, 
patient basis because of inadequate sampling! 
and technical or anatomical difficulties. 
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